This small molecule is being tested by scientists at the ALS Therapy Development Institute for its potential to help support the unfolded protein response in ALS patients.
Since adding it in January of 2015, we've been able to rapidly move this compound into efficacy testing in SOD1 mice. We are hopeful it will show promise as a treatment for ALS.
Topics in the Pipeline